135 related articles for article (PubMed ID: 25292066)
21. Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression.
Gao T; He B; Pan Y; Xu Y; Li R; Deng Q; Sun H; Wang S
Mol Carcinog; 2015 May; 54(5):359-67. PubMed ID: 24706416
[TBL] [Abstract][Full Text] [Related]
22. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases.
Kim SJ; Park SE; Lee C; Lee SY; Kim IH; An HJ; Oh YK
Gynecol Oncol; 2003 Mar; 88(3):411-8. PubMed ID: 12648595
[TBL] [Abstract][Full Text] [Related]
23. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition.
Cruz-Correa M; Cui H; Giardiello FM; Powe NR; Hylind L; Robinson A; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Feinberg AP
Gastroenterology; 2004 Apr; 126(4):964-70. PubMed ID: 15057734
[TBL] [Abstract][Full Text] [Related]
24. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
Wu J; Qin Y; Li B; He WZ; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
[TBL] [Abstract][Full Text] [Related]
25. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
Li H; Zhang N
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
[TBL] [Abstract][Full Text] [Related]
26. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
[TBL] [Abstract][Full Text] [Related]
27. Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.
Zhao R; DeCoteau JF; Geyer CR; Gao M; Cui H; Casson AG
Carcinogenesis; 2009 Dec; 30(12):2117-22. PubMed ID: 19843644
[TBL] [Abstract][Full Text] [Related]
28. Genomic imprinting of IGF-II and H19 in adult human pancreatic tissues.
Micha AE; Hähnel S; Friess H; Büchler MW; Adler G; Gress TM
Digestion; 1999; 60(5):477-83. PubMed ID: 10473973
[TBL] [Abstract][Full Text] [Related]
29. Distinct allelic expression patterns of imprinted
Ozaki S; Kawahara E; Maenaka S; Hoang NV; Oyama T; Imai M; Oda M; Yano S
Oncol Lett; 2014 Dec; 8(6):2561-2564. PubMed ID: 25364428
[TBL] [Abstract][Full Text] [Related]
30. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
31. Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma.
Kohda M; Hoshiya H; Katoh M; Tanaka I; Masuda R; Takemura T; Fujiwara M; Oshimura M
Mol Carcinog; 2001 Aug; 31(4):184-91. PubMed ID: 11536368
[TBL] [Abstract][Full Text] [Related]
32. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas.
Rainho CA; Kowalski LP; Rogatto SR
Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232
[TBL] [Abstract][Full Text] [Related]
33. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
34. Loss of imprinting and promoter usage of the IGF2 in laryngeal squamous cell carcinoma.
Grbesa I; Ivkic M; Pegan B; Gall-Troselj K
Cancer Lett; 2006 Jul; 238(2):224-9. PubMed ID: 16111804
[TBL] [Abstract][Full Text] [Related]
35. Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
Mummert SK; Lobanenkov VA; Feinberg AP
Genes Chromosomes Cancer; 2005 Jun; 43(2):155-61. PubMed ID: 15761865
[TBL] [Abstract][Full Text] [Related]
36. [Altered genomic imprinting in the IGF2 and H19 genes in human lung cancer].
Kondo M; Takahashi T
Nihon Rinsho; 1996 Feb; 54(2):492-6. PubMed ID: 8838103
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.
Belharazem D; Magdeburg J; Berton AK; Beissbarth L; Sauer C; Sticht C; Marx A; Hofheinz R; Post S; Kienle P; Ströbel P
J Gastroenterol; 2016 Oct; 51(10):971-84. PubMed ID: 26984550
[TBL] [Abstract][Full Text] [Related]
38. Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer.
Cui H
Dis Markers; 2007; 23(1-2):105-12. PubMed ID: 17325430
[TBL] [Abstract][Full Text] [Related]
39. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors.
Ross JA; Schmidt PT; Perentesis JP; Davies SM
Cancer; 1999 Mar; 85(6):1389-94. PubMed ID: 10189147
[TBL] [Abstract][Full Text] [Related]
40. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]